Updated Sep 19, 2022 17:16

Market for Penicillins Or Streptomycins Medicaments in Indonesia

Market Overview
Please note: Annual data for 2022 are preliminary and subject to revision
After five years of growth, the Indonesian penicillins or streptomycins medicaments market decreased by -% to $ in . Over the period under review, consumption, however, posted a prominent expansion. Penicillins or streptomycins medicaments consumption peaked at $ in , and then reduced modestly in the following year.

In value terms, penicillins or streptomycins medicaments production fell slightly to $ in estimated in export price. Over the period under review, production, however, continues to indicate a buoyant expansion. The growth pace was the most rapid in 2016 when the production volume increased by %. Over the period under review, production hit record highs at $ in , and then reduced slightly in the following year.


Consumption
Please note: Annual data for 2022 are preliminary and subject to revision
In , approx. tons of medicaments of penicillins, streptomycins or derivatives thereof were consumed in Indonesia; growing by % against figures. Overall, consumption saw a buoyant expansion. Over the period under review, consumption attained the peak volume in and is likely to continue growth in the near future.

The revenue of the penicillins or streptomycins medicaments market in Indonesia reached $ in , picking up by % against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Over the period under review, consumption recorded a strong expansion. Penicillins or streptomycins medicaments consumption peaked in and is likely to see gradual growth in years to come.


Market Forecast
Please note: Annual data for 2022 are preliminary and subject to revision
Driven by increasing demand for penicillins or streptomycins medicaments in Indonesia, the market is expected to continue an upward consumption trend over the next eight-year period. Market performance is forecast to decelerate, expanding with an anticipated CAGR of +% for the period from to , which is projected to bring the market volume to tons by the end of .

In value terms, the market is forecast to increase with an anticipated CAGR of +% for the period from to , which is projected to bring the market value to $ (in nominal prices) by the end of .


Market Structure
Please note: Annual data for 2022 are preliminary and subject to revision
Over the period under review, imports of penicillins or streptomycins medicaments in Indonesia were negligibly small compared to the production volumes. Therefore, the share of imports in the total market was practically nonexistent, both in volume and in value terms. This situation has remained constant over the period under review, which means that domestic producers entirely meet the domestic demand for penicillins or streptomycins medicaments. In , the share of imports in total consumption accounted for % in value terms and % in physical terms. The share of imports remained relatively constant over the period under review. In , the share of imports in total consumption accounted for % in value terms and % in physical terms. The share of imports decreased moderately (- percentage point) over the period under review.


Trade Balance
Please note: Annual data for 2022 are preliminary and subject to revision
Indonesia remains a net exporter of penicillins or streptomycins medicaments; in physical and value terms, exports consistently exceeded imports from 2007 to . In , there was a significant trade surplus of tons, which was equal to $. This tangible trade surplus reflects the fact that the market remains buoyed by domestic production, and the industry is highly incorporated into the global market, which is likely to continue in the medium term.